Xiao Liu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital · ORCID：0000-0001-5173-6075

发表论文 49 篇 · 总被引 722 次 · h-index 9

代表论文

• Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway (2020 · Aging · 被引 273)
• Characteristics of serum metabolites in sporadic amyotrophic lateral sclerosis patients based on gas chromatography-mass spectrometry (2021 · Scientific Reports · 被引 23)
• Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review (2023 · Cancers · 被引 17)
• Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study (2025 · Journal of Hepatocellular Carcinoma · 被引 8)
• Research trends of cellular immunotherapy for primary liver cancer: A bibliometric analysis (2024 · Human Vaccines & Immunotherapeutics · 被引 6)
• 20S-Ginsenoside Rh2, the major bioactive saponin in Panax notoginseng flowers, ameliorates cough by inhibition of NaV1.7 and TRPV1 channel currents and downregulation of TRPV1 expression (2024 · Journal of Ethnopharmacology · 被引 6)